| Can network pharmacology rescue neutraceutical cancer research? | |
| | |
MedLine Citation:
|
PMID: 22727577 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
|
Authors:
|
Asfar S Azmi; Ramzi M Mohammad; Fazlul H Sarkar |
Related Documents
:
|
20503777 - Helmholtz's early empiricism and the erhaltung der kraft. 8999277 - Locating the stranger rapist. 17804257 - Mountains and valleys: binocular rivalry and the flow of experience. 23146607 - Latino immigration and white, black, and latino violent crime: a comparison of traditio... 23584567 - Measuring collective efficacy among children in community-based afterschool programs: e... 16363937 - Responsible animal-based research: three flags to consider. |
Publication Detail:
|
Type: EDITORIAL Date: 2012-6-16 |
Journal Detail:
|
Title: Drug discovery today Volume: - ISSN: 1878-5832 ISO Abbreviation: - Publication Date: 2012 Jun |
Date Detail:
|
Created Date: 2012-6-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9604391 Medline TA: Drug Discov Today Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Novel Myoclonin1/EFHC1 mutations in Mexican patients with juvenile myoclonic epilepsy.
Next Document: Enhancing public trust in the food safety regulatory system.